+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Oxaprozin and sulindac in rheumatoid arthritis: a double-blind comparative trial



Oxaprozin and sulindac in rheumatoid arthritis: a double-blind comparative trial



Current Medical Research and Opinion 8(5): 302-309



Oxaprozin, an anti-inflammatory agent with a half-life of 50 hours, was compared in regard to efficacy and tolerance with sulindac in a 12-week double-blind parallel treatment trial of rheumatoid arthritis. Oxaprozin was given as a single morning daily dose of 1200 mg, sulindac was given as 200 mg twice daily. Analysis of the results from the 20 patients (10 in each group) who completed the trial indicated that both drugs produced statistically significant improvement in morning stiffness, walking speed and the Ritchie index, but only sulindac produced significant improvement in hand function. Neither drug was associated with significant side-effects.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 043867149

Download citation: RISBibTeXText

PMID: 6340971

DOI: 10.1185/03007998309112388


Related references

Oxaprozin versus aspirin in rheumatoid arthritis: a double-blind trial. Current Medical Research and Opinion 5(6): 433-438, 1978

A double-blind, crossover trial of mefenamic acid, sulindac and flurbiprofen in rheumatoid arthritis. Current Medical Research and Opinion 5(10): 754-758, 1979

A multicenter double blind comparison of oxaprozin aspirin therapy on rheumatoid arthritis. Journal of International Medical Research 7(1): 69-76, 1979

A double blind multicenter study of sulindac once daily versus sulindac twice daily in rheumatoid arthritis. Current Therapeutic Research 41(5): 679-691, 1987

A double-blind study comparing sulindac with indomethacin in rheumatoid arthritis. Scandinavian Journal of Rheumatology. Supplement 37: 1-6, 1980

A Double-blind Study Comparing Sulindac with Indomethacin in Rheumatoid Arthritis. Scandinavian Journal of Rheumatology 10(S37): 1-6, 1981

A double-blind comparative trial of cyclophosphamide and gold in rheumatoid arthritis. Annals of the Rheumatic Diseases 33(6): 574, 1974

Ibuprofen and diflunisal in rheumatoid arthritis: a double-blind comparative trial. New Zealand Medical Journal 94(688): 45-47, 1981

A comparative, double-blind trial with proquazone and naproxen in the treatment of rheumatoid arthritis. Scandinavian Journal of Rheumatology. Supplement 1978(21): 33-35, 1978

Proceedings: A double-blind comparative trial of cyclophosphamide and gold in rheumatoid arthritis. Annals of the Rheumatic Diseases 33(6): 574-574, 1974

Double blind trial of the comparative efficacy of voltaren and naproxen in rheumatoid arthritis. Terapevticheskii Arkhiv 53(7): 111-114, 1981

Comparative double blind trial of pirprofen, indomethacin, and placebo in the treatment of rheumatoid arthritis. La Nouvelle Presse Medicale 11(33): 2484-2486, 1982

Tenoxicam vs. delayed release diclofenac sodium in the treatment of rheumatoid arthritis a double blind comparative trial. Folha Medica 98(5): 337-344, 1989

Multicenter double blind study of the efficacy safety and tolerance of pirazolac compared with sulindac in patients with rheumatoid arthritis. Drugs under Experimental & Clinical Research 16(1): 17-28, 1990

Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial. Clinical Therapeutics 29(5): 862-873, 2007